Navigation Links
Clinical trial will test new HIV/AIDS vaccine
Date:4/3/2008

BOSTON A phase 1 clinical trial to test a novel HIV/AIDS vaccine has begun at Brigham and Womens Hospital (BWH). This new vaccine aims to overcome the problem of preexisting immunity to common vaccine vectors, which is thought to be a major problem in the developing world.

This study will involve 48 healthy volunteers who will receive either two or three immunizations and who will be followed to assess the safety and immunogenicity of the vaccine, explains Lindsey R. Baden, MD, Assistant Professor of Medicine at BWH and Harvard Medical School and Protocol Chair for the study.

The vaccine consists of a replication-incompetent, recombinant adenovirus serotype 26 (rAd26) vector encoding an HIV-1 envelope gene.

The rAd26 vaccine vector was selected for its particularly low seroprevalence in human populations and for its potent immunogenicity and protective efficacy in preclinical studies, explains Dan H. Barouch, MD, PhD, Associate Professor of Medicine at Beth Israel Deaconess Medical Center (BIDMC) and Harvard Medical School and Principal Investigator of the Integrated Preclinical/Clinical AIDS Vaccine Development (IPCAVD) program that developed the vaccine. This program is sponsored by the Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health.

Manufactured by the Dutch biotechnology company Crucell Holland BV, the rAd26 vaccine is the first HIV-1 vaccine candidate to emerge from the IPCAVD initiative, which brings together investigators from academia and industry in an effort to accelerate the development of promising HIV/AIDS vaccine candidates. The novel strategy used in developing this vaccine enables researchers to circumvent preexisting immunity to the adenovirus serotype 5, the virus responsible for the common cold, which has recently shown limitations as an HIV-1 vaccine vector.

The rAd26 vector does not regularly occur in the human population and huma
'/>"/>

Contact: Bonnie Prescott
bprescot@bidmc.harvard.edu
617-667-7306
Beth Israel Deaconess Medical Center
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Radiologists encouraged to look beyond cancer for clinically unseen diseases
2. Clinical depression linked to abnormal emotional brain circuits
3. Preclinical study suggests organ-transplant drug may aid in lupus fight
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Good Clinical Practice Journal Awards: Winners Announced
6. Microsoft Helps Developers of Clinical User Interfaces Improve Efficiency, Patient Safety With Free Toolkit
7. Study Questions Dead-End Cancer Clinical Trials
8. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
9. Clinical trials present better alternatives for dialysis patients
10. Mirixa Debuts New Clinical Technology Solutions for Enhancing Patient Care
11. IMPACT initiative looks to improve patient participation in clinical trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... On December 9, 2009, the United States Court of ... private insurance companies are "plans" and therefore subject to ... courts have held that contracts issued by insurance companies ... Section 1347, US vs. Frost is the ... to be a "plan," because, as the government claimed ...
(Date:12/14/2009)... shouldn,t worry most users, researcher says , , MONDAY, Dec. ... may have a small but statistically significant increased risk ... the medications, a new study finds. , "But statistical ... Jordan W. Smoller, an associate professor of psychiatry at ... in the Dec. 14 issue of Archives of ...
(Date:12/14/2009)... are underdiagnosed, poorly treated and highly stigmatized, according ... H. Rubin, M.D., Ph.D. So these Washington University ... problems. , In "Demystifying Psychiatry," Zorumski and Rubin, ... treating psychiatric patients and helping patient families, say ... and treatment result from a lack of understanding ...
(Date:12/14/2009)... for Biopsy , ... Newport News, ... today that the U.S. Food and Drug Administration (FDA) has ... biopsy guidance. , , ,GammaLMc® is a complementary technology ... GammaLMc® (GL) system will help doctors accurately locate breast lesions ...
(Date:12/14/2009)... Concetta F. Conkling of Moraga, CA, retired Senior Vice ... been elected Chair of the Board of Trustees of the ... 90-year-old organization to which Helen Keller devoted more than ... with offices in San Francisco, Dallas, Atlanta, ... to expanding possibilities for people with vision loss. ,, ...
Breaking Medicine News(10 mins):Health News:Insurance Now Subject to Federal Jurisdiction 2Health News:Antidepressants May Raise Women's Stroke Risk 2Health News:Antidepressants May Raise Women's Stroke Risk 3Health News:Book demystifies psychiatry for the general public 2Health News:Book demystifies psychiatry for the general public 3Health News:Dilon Diagnostics Gamma-Guided Localization System Cleared by FDA 2Health News:The American Foundation for the Blind Welcomes New Board Chair, Concetta F. Conkling 2
... U.S. hospitals on the East coast distribute formula sample ... major medical organizations concerned about the potential for distributing ... report in the September issue of Archives of ... journals. However, the practice is changing significantly. , "Packaged ...
... Thompson, Clegg in St. Paul, SILVER SPRING, Md., ... applauded the GOP Platform Committee,s,action, stating: "The growing awareness ... the national and local levels as our policymakers seek,ways ... shine a spotlight on,this issue and lead to practical ...
... it predicted outcome months after patient went home , , ... sleep during the day while in rehabilitation have less ... which was expected to be published in the Sept. ... sleeping patterns and other predictors of recovery (e.g., mental ...
... Force and Air Mobility Command have evacuated more than 3,100 passengers ... combination of Active duty, Air Force Reserve and commercially-contracted flights. ... ... and Air Mobility Command have evacuated more than 3,100 passengers from ...
... polymer , , MONDAY, Sept. 1 (HealthDay News) -- One ... equally effective as older models in boosting outcomes for ... are tiny mesh tubes inserted into arteries to keep ... reclosure. The latest form of drug-eluting stents releases the ...
... Sept. 1 The California,Nurses Association/National Nurses Organizing Committee ... Medicare for,all, style bill that would guarantee quality health ... for the national healthcare reform,debate that is sure to ... Senator Sheila Kuehl, passed its final,legislative hurdle with a ...
Other Medicine News:Health News:Hospitals provide formula sample packs while medical organizations encourage breastfeeding 2Health News:The Obesity Society Hails Republican Platform; Forum Set for Sept. 2 to Continue as Planned 2Health News:Daytime Sleeping Linked to Poor Recovery in Older Patients 2Health News:Air Force Hurricane Gustav Support 2Health News:New Type of Stent Appears Safe, Effective 2Health News:Calif. Nurses Laud Passage of Single-Payer, SB 840, Seen as National Model for Guaranteed Healthcare for All 2
(Date:12/14/2009)... Pharmaceuticals, Inc. (NYSE: WPI ) today ... help maintain the bone health of prostate cancer ... (ADT). Nearly two million men are receiving ... while highly effective and considered the "gold therapy," ... risk for osteoporosis. ,, As part of the ...
(Date:12/14/2009)... --Ohr Pharmaceutical Inc. (OTC Bulletin Board: OHRP) announced ... headquartered in Irvine, CA, with offices also in ... investor relations and corporate communications. Ohr Pharmaceutical ... developing advanced drugs for underserved therapeutic needs. The ... global markets: OHR/AVR118 for the treatment of Cachexia ...
(Date:12/14/2009)... Calif. and REHOVOT, Israel, Dec. 14 ... technology and services resource for pathologists, oncologists and ... today jointly announced that they will collaborate on ... non-invasive test for the early detection of non-small ... patient,s sputum and was originally developed at the ...
Breaking Medicine Technology:Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 2Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 3Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 4Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 5Ohr Pharmaceutical Selects Allen & Caron for Investor Relations, Corporate Communications 2Ohr Pharmaceutical Selects Allen & Caron for Investor Relations, Corporate Communications 3Clarient, BioView Initiate Alliance to Finalize Development and Commercialize Non-Invasive Molecular Diagnostic Test for Early Detection of Lung Cancer 2Clarient, BioView Initiate Alliance to Finalize Development and Commercialize Non-Invasive Molecular Diagnostic Test for Early Detection of Lung Cancer 3Clarient, BioView Initiate Alliance to Finalize Development and Commercialize Non-Invasive Molecular Diagnostic Test for Early Detection of Lung Cancer 4One Woman Initiative Announces First Grants to Womens Organizations in Five Nations 47833 1One Woman Initiative Announces First Grants to Womens Organizations in Five Nations 47833 2One Woman Initiative Announces First Grants to Womens Organizations in Five Nations 47833 3One Woman Initiative Announces First Grants to Womens Organizations in Five Nations 47833 4UGA grad program expands to prepare teachers to work with secondary students with autism 47829 1UGA grad program expands to prepare teachers to work with secondary students with autism 47829 2UGA grad program expands to prepare teachers to work with secondary students with autism 47829 3First ASMS Hites Award for Outstanding Research Publication Presented to Prof Alison Ashcroft for Her Use of Waters Synapt HDMS System to Explore Pro 12453 1First ASMS Hites Award for Outstanding Research Publication Presented to Prof Alison Ashcroft for Her Use of Waters Synapt HDMS System to Explore Pro 12453 2First ASMS Hites Award for Outstanding Research Publication Presented to Prof Alison Ashcroft for Her Use of Waters Synapt HDMS System to Explore Pro 12453 3
... MEETING, Pa., June 25, 2007 /PRNewswire-FirstCall/ --,Genaera ... preclinical,study of trodusquemine (MSI-1436) for the treatment ... Association (ADA) 67th,Scientific Sessions, June 22-25 in ... and lead author of Abstract #1801-P,presented, "Trodusquemine ...
... Reported Unlike What Is Commonly Seen In,Insulin Therapy, ... announced results of a new study that further ... detemir,[rDNA origin] injection). Patients with type 2 diabetes ... and achieve improvements,in blood sugar, comparable to dosing ...
Other Medicine Technology:Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for,the Treatment of Obesity at the American Diabetes Association 67th,Scientific Session 2Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for,the Treatment of Obesity at the American Diabetes Association 67th,Scientific Session 3Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for,the Treatment of Obesity at the American Diabetes Association 67th,Scientific Session 4New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 2New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 3New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 4New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 5
Insert only, Ethicon, small clip size...
Ethicon, medium-large clip size, 10mm, rotatable take apart...
Solid phase capture sandwich ELISA assay using a microwell format....
... The Smith & Nephew FasT-Fix® Meniscal Repair ... technique that delivers the fixation strength of ... of this next generation system provides the ... minimizing the morbidities associated with suture techniques ...
Medicine Products: